The active ingredient in the vaccine is a sterile filtrate of an alum precipitated anthrax antigen in a solution for injection.
The other ingredients are aluminium potassium sulphate, sodium chloride and purified water. The preservative is thiomersal (0.005%).
Porton Biopharma is the sole manufacturer of the UK’s licensed anthrax vaccine.
The vaccine is manufactured for, and on behalf of, the UK Government. It is supplied for both occupational health purposes and to protect people at risk from potential exposure from the use of anthrax as a biological weapon.
The vaccine can be supplied to other national governments, for more information contact the Commercial department at business@portonbiopharma.com.
The vaccine is given by intramuscular injection and the primary course is comprised of 4 single injections. This is followed by a booster dose every year if there is still a risk of catching anthrax.
For full and detailed product information, please see the MHRA Medicines Information site.
If you are a motivated person who is interested in working in a high-tech environment as part of a dynamic team, then there could be a role for you.
Registered in England and Wales, company number 9331560. Registered office at Manor Farm Road, Porton Down, Salisbury, Wiltshire SP4 0JG. VAT number is GB 206 6518 18.